FY2025 · ended Sep 30, 2025 · Revenue $1.08B, -3.8% YoY · Filed Nov 25, 2025
Embecta Corp. (EMBC) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Sep 30, 2025, it reported revenue of $1.1 billion and net income of $95.4 million. Free cash flow was $182.4 million. As of Jun 30, 2026 it held $214.7 million in cash and investments and $1.5 billion in total debt.
Revenue (TTM)
$1.02B
-7.6% vs year-ago TTM
Net income (TTM)
$87.50M
+4.7% vs year-ago TTM
Operating cash flow (TTM)
$174.10M
+29.6% vs year-ago TTM
Free cash flow (TTM)
$164.60M
+24.4% vs year-ago TTM
EPS (TTM)
$1.47
+3.3% vs year-ago TTM
Dividend per share (TTM)
$0.46
-23.3% vs year-ago TTM
Shares outstanding
58.51M
+0.7% vs prior year
Net cash
$-1.29B
as of Jun 30, 2026
Operating margin
21.9%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- EMBC (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Parsippany, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1872789
- Former names
- Berra Newco, Inc. (until Sep 3, 2021)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Sep 30, 2025 |
FY 2024 Sep 30, 2024 |
FY 2023 Sep 30, 2023 |
FY 2022 Sep 30, 2022 |
|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.1B | $1.1B |
| Operating income | $242.1M | $166.8M | $221.5M | $309.6M |
| Net income | $95.4M | $78.3M | $70.4M | $223.6M |
| Diluted EPS | $1.62 | $1.34 | $1.22 | $3.89 |
| Operating cash flow | $191.7M | $35.7M | $67.7M | $412.2M |
| Free cash flow | $182.4M | $19.9M | $41.2M | $388.6M |
| Total assets | $1.1B | $1.3B | $1.2B | $1.1B |
| Stockholders' equity | -$650.6M | -$738.3M | -$821.7M | -$891.4M |
| Cash and investments | $225.5M | $267.5M | $326.3M | $330.9M |
| Total debt | $1.4B | $1.6B | $1.7B | $1.7B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2026 | Aug 7, 2026 |
| 8-K/A | Amended current report | Jul 31, 2026 | May 15, 2026 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
May 15, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
All 262 Embecta Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.